CRANBURY, N.J.--(BUSINESS WIRE)--Sept. 18, 2006--Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) today announced that the Company is in compliance with NASDAQ’s requirements for continued listing. Accordingly, the Company has been notified by the NASDAQ Listing Qualifications Panel (the “Panel”) that the Company’s delisting hearing before the Panel is no longer necessary and has been cancelled.
